Glenmark Pharma gains on receiving RBI’s nod to raise FII limit to 49%

20 May 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 916.65, up by 17.30 points or 1.92% from its previous closing of Rs. 899.35 on the BSE.

The scrip opened at Rs. 918.20 and has touched a high and low of Rs. 929.90 and Rs. 911.00 respectively. So far 44,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 940.00 on 15-Apr-2015 and a 52 week low of Rs. 512.65 on 20-May-2014.

Last one week high and low of the scrip stood at Rs. 929.90 and Rs. 882.00 respectively. The current market cap of the company is Rs. 24,902.00 crore.

The promoters holding in the company stood at 48.30% while Institutions and Non-Institutions held 40.84% and 10.85% respectively.

Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) to buy up to 49% stake in Glenmark Pharmaceuticals. FIIs through primary market and stock exchanges, can now purchase up to 49% of the paid up capital of the company under the Portfolio Investment Scheme (PIS).

In December, the company had received shareholder nod for enhancing the limit from 40% to 49% for the purchase of its equity shares and convertible debentures by FIIs. As on March 2015, FIIs hold 34.71% stake in the pharma major.

Glenmark Pharmaceuticals is a research-driven, global, integrated pharmaceutical company and ranked among the top 80 Pharma & Biotech companies of the world in terms of revenues as per SCRIP 100 Rankings.

Glenmark Pharma Share Price

1540.70 -52.20 (-3.28%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.